Audrey® H with Lidocaine (1 x 2.0 mL) | South Korea
Short Description
A high-density, structural Hyaluronic Acid dermal filler formulated with 20 mg/mL of cross-linked HA, 0.3% lidocaine, and a high-viscoelastic polymer matrix. Packaged in an economical 2.0 mL high-capacity syringe, Audrey® H (Hard) is specifically engineered for deep subcutaneous and supraperiosteal placement to deliver bone-mimetic structural projection, sharp mandibular contouring, pronounced chin augmentation, and correction of severe facial folds lasting 12 to 18 months.
Detailed Description
Audrey® H with Lidocaine is an advanced, sterile, non-pyrogenic physiological cross-linked sodium hyaluronate injectable manufactured in South Korea. Formulated as the high-density structural cornerstone (“Hard” type) of the Audrey filler collection, it is engineered to reconstruct lost skeletal foundations, correct pronounced facial volume deflation, and sculpt crisp facial profiles.
Produced via non-animal bacterial bio-fermentation, Audrey H utilizes a densely cross-linked 3D polymeric hydrogel network. This molecular architecture delivers a high elastic modulus ($G’$) and cohesive strength, giving the gel the mechanical stability required to resist lateral deformation and compression from hyperactive facial muscles (such as the masseter and mentalis complexes).
Subjected to exhaustive multi-stage dialysis and purification protocols, unreacted BDDE monomers and bacterial endotoxins are reduced to non-detectable trace levels, substantially lowering the incidence of post-procedure erythema, tissue swelling, and delayed immune hypersensitivity. With its high-capacity 2.0 mL syringe format, Audrey H offers clinicians double the product volume of conventional 1.0 mL syringes, providing complete full-face contouring capability in a single unit.
Treatment Areas & Indications
-
Lower Face Contouring & Profile Harmonization:
-
Chin augmentation, anterior projection, and vertical elongation (microgenia / retrogenia correction)
-
Mandibular angle sharpening and linear jawline definition
-
Deep pre-jowl sulcus structural effacement
-
-
Midface Bone-Mimetic Volumization:
-
Malar and zygomatic arch deep structural projection
-
Correction of severe midface volume deficit and submalar fat pad atrophy
-
-
Deep Facial Folds & Depressions:
-
Severe nasolabial folds requiring deep structural foundation support
-
Deep labiomental groove (mental crease between lower lip and chin)
-
Severe marionette creases and oral commissure structural lifting
-
-
Non-Surgical Rhinoplasty:
-
Nasal dorsum elevation, bridge straightening, and structural tip refinement
-
Key Clinical Advantages
-
High-Capacity 2.0 mL Volume: Packed in a 2.0 mL pre-filled syringe format, providing double the volume of standard 1.0 mL industry alternatives for multi-area structural contouring (e.g., bilateral jawline definition or combined chin and cheek projection).
-
High Elastic Modulus ($G’$) & Projection: Generates high resistance to muscular compression, delivering crisp, bone-mimetic projection that holds its vertical height without flattening or spreading laterally.
-
Exhaustive Dialysis Purification: Rigorous washing cycles eliminate residual cross-linking agents and endotoxins, significantly minimizing post-treatment edema, erythema, and clinical downtime.
-
Cohesive Resistance to Migration: The dense 3D polymer lattice keeps deep supraperiosteal boluses securely anchored at the intended anatomical plane, preventing unwanted migration into adjacent soft tissues.
-
Integrated 0.3% Lidocaine: Infused with lidocaine hydrochloride to desensitize deep tissues during needle or cannula extrusion, ensuring high patient comfort throughout high-resistance structural delivery.
-
Extended Clinical Longevity: The densely cross-linked matrix resists endogenous hyaluronidase breakdown and free-radical shear, sustaining structural volume for 12 to 18 months.
Technical Specifications
| Parameter | Specification |
| Active Substance | Cross-linked Sodium Hyaluronate + 0.3% Lidocaine Hydrochloride |
| HA Concentration | 20 mg/mL (High-density structural matrix) |
| Lidocaine Concentration | 3 mg/mL (0.3% w/v) |
| Cross-Linking Technology | Multi-Stage High-Viscoelastic 3D Polymer Matrix (BDDE-based) |
| Syringe Volume | 1 x 2.0 mL pre-filled sterile glass syringe (Total 2.0 mL) |
| Included Needles | 2 x 25G 1/2” (13 mm) or 27G 1/2” ultra-thin wall disposable needles |
| Target Injection Plane | Deep subcutaneous layer or supraperiosteal (pre-periosteal) plane |
| Recommended Injection Tools | 25G / 27G needle or 22G / 25G blunt-tip microcannula |
| Expected Clinical Duration | 12 to 18 months (dependent on anatomical site, depth, and patient tissue metabolism) |
| Storage Instructions | Store between 2°C to 25°C (36°F to 77°F); protect from direct sunlight and freezing |
| Origin / Manufacturer | South Korea (Maypharm / Ostin Bio) |
| Regulatory Category | Medical Device / CE-marked / Prescription Only (Rx) |
Professional Advisory: Audrey® H with Lidocaine is an authentic high-density medical injectable intended strictly for certified dermatologists, plastic surgeons, and credentialed aesthetic injectors trained in deep periosteal delivery, facial danger zones, and vascular mapping. Not intended for superficial intradermal injection or non-clinical consumer use.






Reviews
There are no reviews yet.